Monolayer osmotic pump controlled releasing tablets of nimodipine

An osmotic pump controlled-release, dipine monolayer technology, applied in the field of medicine, can solve the problems of many times of taking medicines, inconvenient taking, large fluctuations in blood drug concentration, etc., and achieve the effects of stable curative effect, long-lasting effect, and small toxic and side effects.
CN1552323AInactive Publication Date: 2004-12-08SHENYANG PHARMA UNIVERSITY
0 Cites 14 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SHENYANG PHARMA UNIVERSITY
Publication Date
2004-12-08
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

A release controlled nisoldipine tablet with single-layer osmotic pump for treating hypertension, angina pectoris, heart failure, etc contains nisoldipine, the release-controlling auxidiary chosen from sodium chloride, potassium chloride, glyceride behenate, etc, and other auxiliaries. Its advantages are sure and durable curative effect and low toxic by-effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention relates to the technical field of medicine, in particular to a nisoldipine monolayer osmotic pump controlled-release tablet for treating hypertension, angina pectoris, left ventricular dysfunction and congestive heart failure. Background technique:

[0002] The common tablet of nisoldipine available in the market is frequently taken, which is inconvenient to take, and the blood concentration fluctuates greatly. Invention content:

[0003] The purpose of the present invention is to provide a nisoldipine single-layer osmotic pump controlled-release tablet with convenient administration, long-lasting effect, stable curative effect and little toxic and side effects.

[0004] The purpose of the present invention is achieved like this:

[0005] Preparation of the present invention contains following components by weight percentage:

[0006] Nisoldipine 1-20%

[0007] Excipients for controlled release 30-90%

[0008] Other excipients bala...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More